Cargando…

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome

Type 2 receptors for vascular endothelial growth factor are believed to be involved in the pathophysiology of ovarian hyperstimulation syndrome (OHSS). The objective of this study was to examine the preventive effects of cabergoline on OHSS and its complications. The study is a non randomized clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosseini, Marzieh Agha, Aleyasin, Ashraf, Mahdavi, Atossa, Nezami, Romina, Safdarian, Leila, Fallahi, Parvin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shiraz University of Medical Sciences 2011
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556762/ https://www.ncbi.nlm.nih.gov/pubmed/23359545

Ejemplares similares

Outcomes of assisted reproduction treatment after dopamine agonist -cabergoline- for prevention of ovarian hyper stimulation syndrome
por: Movahedi, Shohreh, et al.
Publicado: (2016)

Embryo transfer in days 2 to 4 following intracytoplasmic sperm injection: a prospective cohort study
por: Mahdavi, Atossa, et al.
Publicado: (2015)

Prediction of assisted reproductive technique outcome in elevated early follicular phase follicle stimulating hormone with Mullerian inhibiting substance level
por: Safdarian, Leili, et al.
Publicado: (2012)

Comparison of Cabergoline and Quinagolide in Prevention of Severe Ovarian Hyperstimulation Syndrome among Patients Undergoing Intracytoplasmic Sperm Injection
por: Taheripanah, Robabeh, et al.
Publicado: (2018)

Comparison of albumin and cabergoline in the prevention of ovarian hyperstimulation syndrome: A clinical trial study
por: Torabizadeh, Aalie, et al.
Publicado: (2013)

Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?
por: Rubenfeld, Eryn Sara, et al.
Publicado: (2021)

GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial
por: Fouda, Usama M., et al.
Publicado: (2016)

Evaluation of intravenous hydroxylethyl starch, intravenous albumin 20%, and oral cabergoline for prevention of ovarian hyperstimulation syndrome in patients undergoing ovulation induction
por: Ghahiri, Ataollah, et al.
Publicado: (2015)

High Dose Cabergoline in Management of Bilateral Ovarian Hyperstimulation Syndrome: A Case Report
por: Manalai, Gulparkha, et al.
Publicado: (2021)

Calcium gluconate infusion is as effective as the vascular endothelial growth factor antagonist cabergoline for the prevention of ovarian hyperstimulation syndrome
por: Naredi, Nikita, et al.
Publicado: (2013)

Low-dose hCG as trigger day and 35 hr later have different ovarian hyperstimulation syndrome occurrence in females undergoing In vitro fertilization: An RCT
por: Aghahosseini, Marzieh, et al.
Publicado: (2017)

Endometrial Preparation for Women Undergoing Embryo Transfer Frozen-Thawed Embryo Transfer With and Without Pretreatment With Gonadotropin Releasing Hormone Agonists
por: Movahedi, Shohreh, et al.
Publicado: (2018)

Can letrozole plus HMG protocol improve pregnancy outcomes in frozen-thawed embryo transfer? An RCT
por: Aleyasin, Ashraf, et al.
Publicado: (2017)

Pre-curettage cerclage in a viable triplet cervical pregnancy: A case report and review of literature
por: Mahdavi, Atossa, et al.
Publicado: (2019)

In vitro fertilization outcome in frozen versus fresh embryo transfer in women with elevated progesterone level on the day of HCG injection: An RCT
por: Aghahosseini, Marzieh, et al.
Publicado: (2017)

Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoing in vitro fertilization/intracytoplasmic sperm injection treatment cycles: A randomized controlled study
por: Kılıç, Niyazi, et al.
Publicado: (2015)

Prevention of Ovarian Hyperstimulation Syndrome: A Review
por: Smith, Vinayak, et al.
Publicado: (2015)

Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011)

GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome
por: Alama, Pilar, et al.
Publicado: (2013)

Recurrent IVF failure and hereditary thrombophilia
por: Safdarian, Leila, et al.
Publicado: (2014)

Large-Volume Paracentesis, up to 27 L, With Adjuvant Vaginal Cabergoline in the Case of Severe Ovarian Hyperstimulation Syndrome with Successful Pregnancy Outcome: A Case Report
por: Agarwal, Nupur, et al.
Publicado: (2017)

Investigation of anti-mullerian hormone (AMH) level and ovarian response in infertile women with endometriosis in IVF cycles
por: Safdarian, Leili, et al.
Publicado: (2018)

Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis
por: Mahajan, Nalini, et al.
Publicado: (2015)

Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage
por: Huang, Jianfang, et al.
Publicado: (2022)

Comparison of bromocriptine and hydroxyethyl starch in the prevention of ovarian hyperstimulation syndrome
por: Zhang, Qiaoli, et al.
Publicado: (2022)

A treatment approach of severe vulvar edema in ovarian hyperstimulation syndrome patient: A case report
por: Sadeghi, Leila, et al.
Publicado: (2023)

Ovarian Hyperstimulation Syndrome, the Master of Disguise?
por: Ironside, Emily Charlotte, et al.
Publicado: (2015)

Can Laparoscopic Cystectomy Improve Pregnancy Outcomes in Endometrioma? A Prospective Clinical Trial Study
por: Hosseinimousa, Sedigheh, et al.
Publicado: (2022)

Natural cycle versus artificial cycle in frozen-thawed embryo transfer: A randomized prospective trial
por: Agha-Hosseini, Marzieh, et al.
Publicado: (2018)

Letrozole and Ovarian Hyperstimulation Syndrome (OHSS): A Promising Prevention Strategy
por: Di Guardo, Federica, et al.
Publicado: (2023)

Ovarian and intellectual hyperstimulation
por: Quaas, Alexander M.
Publicado: (2021)

Ovarian Hyperstimulation Syndrome as an Etiology of Obstructive Uropathy
por: Marak, Creticus P., et al.
Publicado: (2013)

Radiological Illustration of Spontaneous Ovarian Hyperstimulation Syndrome
por: Mittal, Kartik, et al.
Publicado: (2015)

Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
por: Gómez, Gemma Grau, et al.
Publicado: (2019)

Interleukin-2 and SOCS-1 proteins involvement in the pathophysiology of severe ovarian hyperstimulation syndrome-a preliminary proof of concept
por: Orvieto, Raoul, et al.
Publicado: (2014)

Ovarian Hyperstimulation Syndrome: Current Views on Pathophysiology, Risk Factors, Prevention, and Management
por: Alper, Michael M, et al.
Publicado: (2009)

Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment
por: Fiedler, Klaus, et al.
Publicado: (2012)

Outpatient Management of Severe Ovarian Hyperstimulation Syndrome (OHSS) with Placement of Pigtail Catheter
por: Abuzeid, M., et al.
Publicado: (2014)

The effect of metabolic syndrome on controlled ovarian stimulation outcome in infertile women with polycystic ovary syndrome undergoing assisted reproductive technology cycles
por: Moini, Ashraf, et al.
Publicado: (2022)

Ovarian hyperstimulation syndrome (OHSS) at a maternity hospital
por: Lappas, V, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_dc99ur5j0lam47vhnc5i45862a